Citation Impact
Citing Papers
International consensus guidance for management of myasthenia gravis
2016 Standout
Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases
2024 StandoutNobel
Geographical Distribution of Myasthenia Gravis in Northern Europe - Results from a Population-Based Study from Two Countries
2015
Lifetime course of myasthenia gravis
2007 Standout
Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in the Netherlands
2006
Myasthenia Gravis
2016 Standout
The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes
2013
Myasthenia in pregnancy: best practice guidelines from a UK multispecialty working group
2013
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Myasthenia gravis and amyotrophic lateral sclerosis: A pathogenic overlap
2016
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Immunostick ELISA for rapid and easy diagnosis of myasthenia gravis
2018
Immunity and Acquired Alterations in Cognition and Emotion: Lessons from SLE
2006
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
2013 Standout
Virchow-Robin spaces on magnetic resonance images: normative data, their dilatation, and a review of the literature
2006
Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools
2017
Neuromuscular junction disorders
2016
Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor
2008
Muscle Giants: Molecular Scaffolds in Sarcomerogenesis
2009
Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4
2013
Risk of extrathymic cancer in patients with myasthenia gravis in Taiwan: a nationwide population‐based study
2012
Epidemiological and immunological profile of muscle‐specific kinase myasthenia gravis in Greece
2009
Myasthenia gravis requiring pyridostigmine treatment in a national population cohort
2010
Cortactin autoantibodies in myasthenia gravis
2014
IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†
2008
Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001
2006
Excessive risk of cancer and in particular lymphoid malignancy in myasthenia gravis patients: A population-based cohort study
2013
Autoantibodies against TRPC3 and ryanodine receptor in myasthenia gravis
2008
The ageing and myasthenic thymus: A morphometric study validating a standard procedure in the histological workup of thymic specimens
2008
Myasthenia gravis – diagnostikk og behandling
2016
Induction of Anti-agrin Antibodies Causes Myasthenia Gravis in Mice
2018
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
2009 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
A systematic review of population based epidemiological studies in Myasthenia Gravis
2010 Standout
Autoimmune Targets of Heart and Skeletal Muscles in Myasthenia Gravis
2009
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
2007 Standout
Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis
2010 Standout
Late Onset Myasthenia Gravis Is Associated with HLA DRB1*15:01 in the Norwegian Population
2012
Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force
2010
Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase
2013
Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens
2013
Seronegative myasthenia gravis associated with malignant thymoma
2017
T Helper Type 17 Cells Expand in Patients with Myasthenia‐Associated Thymoma
2012
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia
2010 Standout
Myasthenia gravis: past, present, and future
2006
The Glymphatic System: A Beginner’s Guide
2015 Standout
Myasthenia gravis
2019 Standout
Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms
2014
Factors affecting outcome in myasthenia gravis
2016
N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
2010 Standout
The search for new antigenic targets in myasthenia gravis
2012
Thymoma and the increased risk of developing extrathymic malignancies: a multicentre study†
2013
Clinical and serological study of myasthenia gravis in HuBei Province, China
2006
A study of the utility of azathioprine metabolite testing in myasthenia gravis
2016
Comparing the Autoantibody Levels and Clinical Efficacy of Double Filtration Plasmapheresis, Immunoadsorption, and Intravenous Immunoglobulin for the Treatment of Late‐onset Myasthenia Gravis
2009
Polygenic Disease Associations in Thymomatous Myasthenia Gravis
2007
IgG4-related disease
2014 Standout
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
2013 Standout
Advances in the Diagnosis of Neuromuscular Junction Disorders
2005
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
2013 Standout
Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis
2013
Specific removal of autoantibodies by extracorporeal immunoadsorption ameliorates experimental autoimmune myasthenia gravis
2017
Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care
2006
Myasthenia gravis: from autoantibodies to therapy
2018
Guidelines for treatment of autoimmune neuromuscular transmission disorders
2010
Myasthenia gravis and the neuromuscular junction
2013
Thymoma related myasthenia gravis in humans and potential animal models
2015
Update on juvenile myasthenia gravis
2013
Complement associated pathogenic mechanisms in myasthenia gravis
2013
Myasthenia gravis: subgroup classification and therapeutic strategies
2015 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody‐binding epitopes in myasthenia gravis
2013
Paraneoplastic neurological syndromes
2013
Antititin antibody in early- and late-onset myasthenia gravis
2014
A randomized, double‐blind, placebo‐controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis
2013
Diagnostic utility of cortactin antibodies in myasthenia gravis
2017
Myasthenia gravis: an update for the clinician
2013
2015
Thymectomy for non-thymomatous myasthenia gravis
2013
Late-onset myasthenia gravis: A review when incidence in older adults keeps increasing
2013
Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal Muscles
2016
Survey of epidemiology, clinical picture and current treatments for elderly‐onset (≥ 65 years) patients with myasthenia gravis in Nagano Prefecture, Japan
2017
Myasthenia gravis and risks for comorbidity
2014
New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis
2018
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?
2001
Myasthenia and the neuromuscular junction
2012
The Role of Thymomas in the Development of Myasthenia Gravis
2003
Myasthenia and risk of cancer: a population‐based case–control study
2014
Challenging the current model of early‐onset myasthenia gravis pathogenesis in the light of the MGTX trial and histological heterogeneity of thymectomy specimens
2018
Anti-agrin autoantibodies in myasthenia gravis
2014
Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries
2014
Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis
2015
A nationwide epidemiological study of myasthenia gravis in Latvia
2017
Increasing incidence of myasthenia gravis among elderly in British Columbia, Canada
2011
Maternal myasthenia gravis represents a risk for the child through autoantibody transfer, immunosuppressive therapy and genetic influence
2018
Mortality in myasthenia gravis: A nationwide population–based follow‐up study in Denmark
2015
Late‐onset myasthenia not on the increase: a nationwide register study in D enmark, 1996–2009
2012
2014
Use of azathioprine for non‐thymoma myasthenia and risk of cancer: a nationwide case–control study in D enmark
2013
Agrin and LRP4 antibodies as new biomarkers of myasthenia gravis
2018
Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis
2004
Incidence of seropositive myasthenia gravis in Cape Town and South Africa.
2007
Works of Fredrik Romi being referenced
Myasthenia gravis: disease severity and prognosis
2006
Matrix Metalloproteinases in Myasthenia Gravis
2011
The Severity of Myasthenia Gravis Correlates With the Serum Concentration of Titin and Ryanodine Receptor Antibodies
2000
Thymectomy in Nonthymoma Early-Onset Myasthenia gravis in Correlation with Disease Severity and Muscle Autoantibodies
2003
Myasthenia gravis: clinical, immunological, and therapeutic advances
2005
Cystic Dilation of Virchow-Robin Spaces in the Midbrain
2002
The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo
2004
Serum Levels of Matrix Metalloproteinases: Implications in Clinical Neurology
2012
Myasthenia Gravis in Individuals over 40
2003
Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis
2000
Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis
2011
Geographical distribution of A seropositive myasthenia gravis population
2011
Paraneoplastic myasthenia gravis: immunological and clinical aspects
2008
Thymectomy and anti‐muscle autoantibodies in late‐onset myasthenia gravis
2002
Anti-Heat Shock Protein 70 antibody levels are increased in myasthenia gravis and Guillain-Barré syndrome
2010
Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients
2016
Myasthenia gravis and infectious disease
2018
Disease severity and outcome in thymoma myasthenia gravis: a long‐term observation study
2003
Serum matrix metalloproteinase-3 levels are elevated in myasthenia gravis
2008
Extrathymic malignancies in thymoma patients with and without myasthenia gravis
2010
Pathophysiology and immunological profile of myasthenia gravis and its subgroups
2017
Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules
2002
Repeated Acetylcholine Receptor Antibody-Concentrations and Association to Clinical Myasthenia Gravis Development
2014
Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features
2007
Seronegative myasthenia gravis: disease severity and prognosis
2005
Thymectomy and Antimuscle Antibodies in Nonthymomatous Myasthenia Gravis
2003
Striational Antibodies in Myasthenia Gravis
2005
Pathogenesis of Myositis and Myasthenia Associated with Titin and Ryanodine Receptor Antibodies
2003
Heat-Shock Proteins in Clinical Neurology
2011
SEROPOSITIVE MYASTHENIA GRAVIS: A NATIONWIDE EPIDEMIOLOGIC STUDY
2009
Matrix Metalloproteinase-3 in Myasthenia Gravis Compared to Other Neurological Disorders and Healthy Controls
2011
Myasthenia gravis — autoantibody characteristics and their implications for therapy
2016
HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis
2018
Myasthenia Gravis: A Review of Available Treatment Approaches
2011
Multiple antibody detection in ‘seronegative’ myasthenia gravis patients
2017
Muscle autoantibodies in subgroups of myasthenia gravis patients
2000
Thymoma in Myasthenia Gravis: From Diagnosis to Treatment
2011